These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 24394737)
61. Allergy to heparins and anticoagulants with a similar pharmacological profile: an update. Jappe U Blood Coagul Fibrinolysis; 2006 Nov; 17(8):605-13. PubMed ID: 17102645 [TBL] [Abstract][Full Text] [Related]
62. Efficacy and safety of the long-term administration of low-molecular-weight heparins in pregnancy. Santoro R; Iannaccaro P; Prejanò S; Muleo G Blood Coagul Fibrinolysis; 2009 Jun; 20(4):240-3. PubMed ID: 19357505 [TBL] [Abstract][Full Text] [Related]
69. Prevention and Management of Thromboembolism in Pregnancy When Heparins Are Not an Option. James AH Clin Obstet Gynecol; 2018 Jun; 61(2):228-234. PubMed ID: 29470181 [TBL] [Abstract][Full Text] [Related]
70. Hypersensitivity reactions to low molecular weight heparins: different patterns of cross-reactivity in 3 patients. Juricic Nahal D; Cegec I; Erdeljic Turk V; Makar Ausperger K; Kraljickovic I; Simic I Can J Physiol Pharmacol; 2018 Apr; 96(4):428-432. PubMed ID: 28977756 [TBL] [Abstract][Full Text] [Related]
71. Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins: tolerance of a new recombinant hirudin. Koch P; Münssinger T; Rupp-John C; Uhl K J Am Acad Dermatol; 2000 Apr; 42(4):612-9. PubMed ID: 10727306 [TBL] [Abstract][Full Text] [Related]
72. Does Use of Low-Molecular-Weight Heparin during Pregnancy Influence the Risk of Prolonged Labor: A Population-Based Cohort Study. Sandström A; Cnattingius S; Wikström AK; Stephansson O; Iliadou AN PLoS One; 2015; 10(10):e0140422. PubMed ID: 26465918 [TBL] [Abstract][Full Text] [Related]
73. Immediate Type Hypersensitivity to Heparins: Two Case Reports and a Review of the Literature. Cesana P; Scherer K; Bircher AJ Int Arch Allergy Immunol; 2016; 171(3-4):285-289. PubMed ID: 28049195 [TBL] [Abstract][Full Text] [Related]
74. The effect of low molecular weight heparin (dalteparin) on duration and initiation of labour. Isma N; Svensson PJ; Lindblad B; Lindqvist PG J Thromb Thrombolysis; 2010 Aug; 30(2):149-53. PubMed ID: 19949968 [TBL] [Abstract][Full Text] [Related]
76. Everything the clinician needs to know about evidence-based anticoagulation in pregnancy. Scheres LJJ; Bistervels IM; Middeldorp S Blood Rev; 2019 Jan; 33():82-97. PubMed ID: 30107951 [TBL] [Abstract][Full Text] [Related]
77. Skin necrosis at the injection site induced by low-molecular-weight heparin: case report and review. Santamaría A; Romaní J; Souto JC; López A; Mateo J; Fontcuberta J Dermatology; 1998; 196(2):264-5. PubMed ID: 9568422 [TBL] [Abstract][Full Text] [Related]
78. [Low-molecular weight heparins in pregnancy]. Aguilera C; Vallano A Med Clin (Barc); 2002 May; 118(16):634-5. PubMed ID: 12028918 [No Abstract] [Full Text] [Related]
79. Delayed-type hypersensitivity skin reactions to low molecular weight heparins in a pregnant woman. Mora A; Belchi J; Contreras L; Rubio G Contact Dermatitis; 2002 Sep; 47(3):177-8. PubMed ID: 12492563 [No Abstract] [Full Text] [Related]
80. Low molecular weight heparin as cause of liver injury: case report and literature review. Leo M; Ponziani FR; Nesci A; Santoliquido A; Vecchio FM; Francalanci P; Pompili M Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7649-7654. PubMed ID: 31539157 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]